Engineered liver-targeted probiotic nanovesicles overcome oral absorption barriers to cure alcoholic liver disease
Chemical Engineering Journal · 2025-10 · 522 · 167270
DOI: 10.1016/j.cej.2025.167270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2025-10. Verfasst von Xu Zhong und 9 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Liaoning Revitalization Talents Program, Youth Science Fund Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Liaoning Revitalization Talents Program
- Youth Science Fund Project
Zitieren
APA
Zhong, X., Wang, Y., Song, C., Song, X., Zhang, Y., Cao, L., Skirtach, A. G., Song, S., Tan, M., & Su, W. (2025). Engineered liver-targeted probiotic nanovesicles overcome oral absorption barriers to cure alcoholic liver disease. Chemical Engineering Journal, 522, 167270. https://doi.org/10.1016/j.cej.2025.167270
Vancouver
Zhong X, Wang Y, Song C, Song X, Zhang Y, Cao L, et al. Engineered liver-targeted probiotic nanovesicles overcome oral absorption barriers to cure alcoholic liver disease. Chemical Engineering Journal. 2025;522:167270. doi:10.1016/j.cej.2025.167270
BibTeX
@article{Zhong2025,
author = {Zhong, Xu and Wang, Yuxiao and Song, Chen and Song, Xunyu and Zhang, Yinxu and Cao, Lin and Skirtach, Andre G. and Song, Shuang and Tan, Mingqian and Su, Wentao},
title = {Engineered liver-targeted probiotic nanovesicles overcome oral absorption barriers to cure alcoholic liver disease},
journal = {Chemical Engineering Journal},
year = {2025},
volume = {522},
pages = {167270},
doi = {10.1016/j.cej.2025.167270}
}
EUVIMED